KPIs & Operating Metrics(New)
Growth Metrics

Abbott Laboratories (ABT) Operating Income (2016 - 2025)

Historic Operating Income for Abbott Laboratories (ABT) over the last 17 years, with Q3 2025 value amounting to $2.1 billion.

  • Abbott Laboratories' Operating Income rose 1065.09% to $2.1 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $7.7 billion, marking a year-over-year increase of 1522.26%. This contributed to the annual value of $6.8 billion for FY2024, which is 535.66% up from last year.
  • According to the latest figures from Q3 2025, Abbott Laboratories' Operating Income is $2.1 billion, which was up 1065.09% from $2.1 billion recorded in Q2 2025.
  • Over the past 5 years, Abbott Laboratories' Operating Income peaked at $2.9 billion during Q1 2022, and registered a low of $1.3 billion during Q4 2022.
  • Moreover, its 5-year median value for Operating Income was $1.8 billion (2023), whereas its average is $1.9 billion.
  • As far as peak fluctuations go, Abbott Laboratories' Operating Income skyrocketed by 17823.22% in 2021, and later tumbled by 4817.99% in 2023.
  • Abbott Laboratories' Operating Income (Quarter) stood at $2.4 billion in 2021, then crashed by 45.16% to $1.3 billion in 2022, then skyrocketed by 36.5% to $1.8 billion in 2023, then increased by 7.36% to $1.9 billion in 2024, then rose by 7.64% to $2.1 billion in 2025.
  • Its Operating Income was $2.1 billion in Q3 2025, compared to $2.1 billion in Q2 2025 and $1.7 billion in Q1 2025.